Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Anti-microbial Agents
1.2.3 Antibiotic Lock Therapy
1.3 Market by Application
1.3.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Perspective (2018-2033)
2.2 Catheter-Related Bloodstream Infections (CRBSIs) Growth Trends by Region
2.2.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Region (2018-2023)
2.2.3 Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2024-2033)
2.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Dynamics
2.3.1 Catheter-Related Bloodstream Infections (CRBSIs) Industry Trends
2.3.2 Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
2.3.3 Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
2.3.4 Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue
3.1.1 Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Revenue (2018-2023)
3.1.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Players (2018-2023)
3.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Catheter-Related Bloodstream Infections (CRBSIs) Revenue
3.4 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio
3.4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2022
3.5 Catheter-Related Bloodstream Infections (CRBSIs) Key Players Head office and Area Served
3.6 Key Players Catheter-Related Bloodstream Infections (CRBSIs) Product Solution and Service
3.7 Date of Enter into Catheter-Related Bloodstream Infections (CRBSIs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Type
4.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Type (2018-2023)
4.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2024-2033)
5 Catheter-Related Bloodstream Infections (CRBSIs) Breakdown Data by Application
5.1 Global Catheter-Related Bloodstream Infections (CRBSIs) Historic Market Size by Application (2018-2023)
5.2 Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2018-2033)
6.2 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023)
6.4 North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2018-2033)
7.2 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023)
7.4 Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2018-2033)
8.2 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2018-2023)
8.4 Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2018-2033)
9.2 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023)
9.4 Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size (2018-2033)
10.2 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023)
10.4 Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals Ltd
11.1.1 Glenmark Pharmaceuticals Ltd Company Detail
11.1.2 Glenmark Pharmaceuticals Ltd Business Overview
11.1.3 Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.1.4 Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.1.5 Glenmark Pharmaceuticals Ltd Recent Development
11.2 Xellia Pharmaceuticals Ltd
11.2.1 Xellia Pharmaceuticals Ltd Company Detail
11.2.2 Xellia Pharmaceuticals Ltd Business Overview
11.2.3 Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.2.4 Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.2.5 Xellia Pharmaceuticals Ltd Recent Development
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Detail
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.3.4 Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.3.5 Fresenius Medical Care Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Detail
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.4.4 Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Geistlich Pharma AG
11.5.1 Geistlich Pharma AG Company Detail
11.5.2 Geistlich Pharma AG Business Overview
11.5.3 Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.5.4 Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.5.5 Geistlich Pharma AG Recent Development
11.6 TauroPhar GmbH
11.6.1 TauroPhar GmbH Company Detail
11.6.2 TauroPhar GmbH Business Overview
11.6.3 TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Introduction
11.6.4 TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
11.6.5 TauroPhar GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Anti-microbial Agents
Table 3. Key Players of Antibiotic Lock Therapy
Table 4. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2018-2023)
Table 8. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2024-2033)
Table 10. Catheter-Related Bloodstream Infections (CRBSIs) Market Trends
Table 11. Catheter-Related Bloodstream Infections (CRBSIs) Market Drivers
Table 12. Catheter-Related Bloodstream Infections (CRBSIs) Market Challenges
Table 13. Catheter-Related Bloodstream Infections (CRBSIs) Market Restraints
Table 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players (2018-2023)
Table 16. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2022)
Table 17. Ranking of Global Top Catheter-Related Bloodstream Infections (CRBSIs) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Catheter-Related Bloodstream Infections (CRBSIs) Product Solution and Service
Table 21. Date of Enter into Catheter-Related Bloodstream Infections (CRBSIs) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2018-2023)
Table 25. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Type (2024-2033)
Table 27. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2018-2023)
Table 29. Global Catheter-Related Bloodstream Infections (CRBSIs) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Catheter-Related Bloodstream Infections (CRBSIs) Revenue Market Share by Application (2024-2033)
Table 31. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Glenmark Pharmaceuticals Ltd Company Detail
Table 47. Glenmark Pharmaceuticals Ltd Business Overview
Table 48. Glenmark Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 49. Glenmark Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 50. Glenmark Pharmaceuticals Ltd Recent Development
Table 51. Xellia Pharmaceuticals Ltd Company Detail
Table 52. Xellia Pharmaceuticals Ltd Business Overview
Table 53. Xellia Pharmaceuticals Ltd Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 54. Xellia Pharmaceuticals Ltd Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 55. Xellia Pharmaceuticals Ltd Recent Development
Table 56. Fresenius Medical Care Company Detail
Table 57. Fresenius Medical Care Business Overview
Table 58. Fresenius Medical Care Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 59. Fresenius Medical Care Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 60. Fresenius Medical Care Recent Development
Table 61. Merck & Co., Inc. Company Detail
Table 62. Merck & Co., Inc. Business Overview
Table 63. Merck & Co., Inc. Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 64. Merck & Co., Inc. Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 65. Merck & Co., Inc. Recent Development
Table 66. Geistlich Pharma AG Company Detail
Table 67. Geistlich Pharma AG Business Overview
Table 68. Geistlich Pharma AG Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 69. Geistlich Pharma AG Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 70. Geistlich Pharma AG Recent Development
Table 71. TauroPhar GmbH Company Detail
Table 72. TauroPhar GmbH Business Overview
Table 73. TauroPhar GmbH Catheter-Related Bloodstream Infections (CRBSIs) Product
Table 74. TauroPhar GmbH Revenue in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023) & (US$ Million)
Table 75. TauroPhar GmbH Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Type: 2022 VS 2033
Figure 3. Anti-microbial Agents Features
Figure 4. Antibiotic Lock Therapy Features
Figure 5. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Catheter-Related Bloodstream Infections (CRBSIs) Report Years Considered
Figure 11. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region: 2022 VS 2033
Figure 14. Global Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Players in 2022
Figure 15. Global Top Catheter-Related Bloodstream Infections (CRBSIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Related Bloodstream Infections (CRBSIs) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Catheter-Related Bloodstream Infections (CRBSIs) Revenue in 2022
Figure 17. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2018-2033)
Figure 19. United States Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2018-2033)
Figure 23. Germany Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Region (2018-2033)
Figure 31. China Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2018-2033)
Figure 39. Mexico Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Catheter-Related Bloodstream Infections (CRBSIs) Market Share by Country (2018-2033)
Figure 43. Turkey Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Catheter-Related Bloodstream Infections (CRBSIs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 46. Xellia Pharmaceuticals Ltd Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 47. Fresenius Medical Care Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 48. Merck & Co., Inc. Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 49. Geistlich Pharma AG Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 50. TauroPhar GmbH Revenue Growth Rate in Catheter-Related Bloodstream Infections (CRBSIs) Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed